BACK
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Ro7568282 In Participants With Early-Stage Parkinson’s Disease (TARBELA-PD)
Principal Investigator
Dr George Tofaris
Contact us
Email:
dendron@ouh.nhs.uk
IRAS number
1014548